Clintrial
Clintrial s.r.o. is a Prague-based contract research organization founded in 2005 that conducts Phase 2 and Phase 3 clinical trials for pharmaceutical sponsors across psychiatry, neurology, dermatology, rheumatology, and other therapeutic areas, recruiting more than 1,000 patients.
- Company typePrivate
- Founded2005
- HeadquartersPrague, Czechia
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Clintrial does
Clintrial s.r.o. is a Prague-based contract research organization (CRO) founded in 2005 that conducts Phase 2 and Phase 3 clinical trials for pharmaceutical and biotech sponsors. The company operates from a single headquarters at Počernická 1427/16 in Prague 10 (Strašnice district) and runs studies across more than 12 therapeutic areas, with primary emphasis on psychiatry and neurology (Alzheimer's, depression, anxiety, schizophrenia, migraine, Parkinson's disease, diabetic neuropathy), dermatology (atopic eczema, psoriasis, acne), and rheumatology (rheumatoid arthritis, osteoarthritis, psoriatic arthritis), plus metabolic, gastrointestinal, cardiovascular, hematology, pulmonology, and gynecology indications. All studies are executed under protocols approved by the Czech State Institute for Drug Control (SÚKL) and relevant ethics committees, leveraging a team of experienced physicians supported by trained study nurses and coordinators.
The business model is professional services revenue from sponsor contracts, with no direct fees charged to participants. Patients (currently more than 1,000 enrolled cumulatively) receive free medical examinations, study treatment, monitoring, and in some cases travel and time compensation. Clintrial recruits through three main channels: a direct-to-consumer funnel via website registration forms, email inquiries, and social media (Facebook, Instagram); a community-led physician referral network spanning 11+ specialties with per-enrollee compensation; and partnerships with affiliated clinics including the sister psychiatric center Psychiatrie Clinterap and neurology partner Euromed Praha 10.
Clintrial is a privately held Czech limited liability company with no disclosed external investors, parent entity, or public listing. The firm has no proprietary technology platform, no AI components, no patents or trademarks disclosed, and no app or API surface. In November 2025, Clintrial published a formal notice of demerger (Oznámení o odštěpení), indicating an internal corporate restructuring. The company continues to actively recruit for new studies as of mid-2026.
Clintrial firmographics
Firmographics- Name
- Clintrial
- Legal name
- CLINTRIAL s.r.o.
- Website
- https://clintrial.cz
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Clintrial s.r.o. is a Prague-based contract research organization founded in 2005 that conducts Phase 2 and Phase 3 clinical trials for pharmaceutical sponsors across psychiatry, neurology, dermatology, rheumatology, and other therapeutic areas, recruiting more than 1,000 patients.
- Ownership category
- akta.pro rank
Clintrial industry classification
Industry- Product category
- Contract Research Organization (CRO) / Clinical Research Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro industry
- Clinical CROs (Phase I–IV)Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)Patient Recruitment, Site Feasibility & Trial Enablement CROsHealthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)
Keywords
Where Clintrial is headquartered
LocationHeadquarters
- HQ city
- Prague
- HQ country
- Czechia
- HQ region
- Europe
Offices1 record
Markets served
Clintrial business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical trial contracts: Contract research organization (CRO) conducting Phase 2 and Phase 3 clinical trials for pharmaceutical companies. Revenue generated from performing clinical evaluations, patient screening, and treatment monitoring according to international clinical trial protocols.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Other | Free clinical trial participation |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Clintrial product offering
Product offeringCore offering
Clintrial is a Czech contract research organization (CRO) that conducts Phase 2 and Phase 3 clinical trials for pharmaceutical sponsors at its single Prague 10 site. The company recruits patients, performs comprehensive medical examinations, and delivers study treatments under SÚKL-approved protocols across specialties such as psychiatry, neurology, dermatology, and rheumatology. Patients receive free examinations, monitoring, and access to modern biological therapies, while the company is paid via clinical trial contracts by pharmaceutical sponsors.
Product overview
Clintrial is a clinical research organization (CRO) providing Phase 2 and Phase 3 clinical trial services. The company operates as a single unified service offering focused on clinical drug evaluations across multiple therapeutic areas including psychiatry/neurology (Alzheimer's, depression, anxiety, schizophrenia, Parkinson's, migraine), dermatology (atopic dermatitis, psoriasis, prurigo nodularis, alopecia areata), rheumatology (rheumatoid arthritis, psoriatic arthritis), and other conditions (diabetic neuropathy, postherpetic neuralgia, sleep disorders). Clintrial recruits patients for clinical trials, provides comprehensive medical examinations, and offers access to modern biological treatments not otherwise available to standard patients.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Trials (Klinické studie) Phase 2 and Phase 3 clinical trial services performed at the Prague 10 site for pharmaceutical sponsors, covering drug evaluations across psychiatry, neurology, dermatology, rheumatology, diabetology, gastroenterology, cardiology, hematology, pneumology, phlebology, and gynecology. Eligible patients receive free examinations, study treatments, and monitoring under SÚKL-approved protocols.
Quantifiable outcome
- More than 1000 clients enrolled in clinical trials
- +1 more outcomes
Companies that use Clintrial
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles3 records
Clintrial technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Clintrial partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- Psychiatrie ClinterapcoreSister psychiatric center operating a network of psychiatric clinics in Prague and Central Bohemian Region. Provides psychiatric expertise and patient referral services for depression, schizophrenia, and anxiety disorder clinical trials. Long-term collaborative relationship in conducting clinical evaluations.
- Neurologie Praha 10 EuromedminorNeurology clinic in Prague 10 providing neurological expertise and patient referrals for neurological condition clinical trials including migraine, Parkinson's disease, and diabetic neuropathy.
Scale indicators3 records
Recent moves7 records
Expansion highlights4 records
Clintrial competitors and assessment
Company assessmentDirect peers
- Medpace: Mid-size CRO specializing in Phase 2/3 clinical trials across multiple therapeutic areas. Closely comparable in business model and target sponsors, though Medpace operates globally with far larger infrastructure.
- Ergomed: European-headquartered CRO providing clinical trial services with strong specialty therapeutic expertise. Comparable in size and Phase 2/3 focus, particularly relevant as a European peer in similar regulation regime.
- Worldwide Clinical Trials: Mid-size global CRO focused on Phase 2/3 trials in CNS, dermatology, and other specialty areas. Directly comparable therapeutic focus and phase positioning to Clintrial, particularly in neurology and dermatology indications.
Broad incumbents
- Tigermed: Asia-based CRO with expanding European operations providing clinical trial services. Comparable in Phase 2/3 CRO service model, increasingly relevant competitor in European trial site selection.
- Parexel: Global CRO offering Phase I–IV clinical trial services and therapeutic area expertise. Comparable service offering for pharma sponsors, especially in neurology and dermatology where Clintrial also operates.
- Charles River Laboratories: Large contract research organization providing clinical and preclinical services. Comparable in serving pharma sponsors with clinical trial services, though broader in scope including non-clinical research.
- IQVIA: Global full-service CRO offering clinical trial management from Phase I to Phase IV across all therapeutic areas. Comparable in offering clinical trial services to pharma sponsors, but operates at vastly larger scale and global footprint.
- Syneos Health: Global biopharmaceutical solutions organization offering clinical development and commercialization services. Comparable in clinical trial service offerings, though significantly larger with broader end-to-end capabilities.
- ICON plc: Major global CRO providing clinical research services across all phases and therapeutic areas. Comparable as a direct competitor for Phase 2/3 trial contracts from pharmaceutical sponsors, though at much greater scale.
Emerging players
- Algorics: Technology-focused clinical services provider offering AI-enabled clinical trial solutions. Comparable as a CRO partner in the trial execution space, though differentiated by technology-led approach that Clintrial lacks.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
Clintrial social profiles
Digital presenceClintrial financial estimates
Financial estimateRevenue estimate
Valuation estimate
Clintrial leadership team
Management profileNumber of profiles
Clintrial funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Clintrial M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Clintrial
What does Clintrial do?
Clintrial is a Czech contract research organization (CRO) that conducts Phase 2 and Phase 3 clinical trials for pharmaceutical sponsors at its single Prague 10 site. The company recruits patients, performs comprehensive medical examinations, and delivers study treatments under SÚKL-approved protocols across specialties such as psychiatry, neurology, dermatology, and rheumatology. Patients receive free examinations, monitoring, and access to modern biological therapies, while the company is paid via clinical trial contracts by pharmaceutical sponsors.
Is Clintrial a public or private company?
Clintrial is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Clintrial founded?
Clintrial was founded in 2005. It employs 11 to 50 people.
Where is Clintrial based?
Clintrial is headquartered in Prague, Czechia, in the Europe region.
How does Clintrial make money?
One revenue line is on record: clinical trial contracts.
Who are Clintrial's main competitors?
Direct peers on record are Medpace, Ergomed and Worldwide Clinical Trials. Broad incumbents are Tigermed, Parexel, Charles River Laboratories, IQVIA, Syneos Health and ICON plc. Algorics is listed as an emerging player.
Does Clintrial have an API?
No public API is recorded for Clintrial.
What industry is Clintrial in?
Clintrial's product category is Contract Research Organization (CRO) / Clinical Research Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs. Its NAICS code is 5417 and its SIC code is 8731.